Patent details

EP3368061 Title: GLUCAGON RECEPTOR AGONISTS

Basic Information

Publication number:
EP3368061
PCT Application Number:
US2016056969
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167856699
PCT Publication Number:
WO2017074715
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLUCAGON RECEPTOR AGONISTS
French Title of Invention:
AGONISTES DU RÉCEPTEUR DU GLUCAGON
German Title of Invention:
GLUCAGONREZEPTORAGONISTEN
SPC Number:

Dates

Filing date:
14/10/2016
Grant date:
07/08/2019
EP Publication Date:
05/09/2018
PCT Publication Date:
04/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/10/2019
Expiration date:
14/10/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Elanco US Inc.
Address:
2500 Innovation Way, Greenfield, IN 46140, United States (US)

Inventor

1

Name:
COSKUN, Tamer
Address:
United States (US)

2

Name:
ALSINA-FERNANDEZ, Jorge
Address:
United States (US)

Priority

Priority Number:
201562246199 P
Priority Date:
26/10/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/26; A61K 45/06; C07K 14/00; C07K 14/605;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages